Evidence map›Paper›PMID 38473313›Full record

ArticleCancers2024

Spontaneous Fusion with Transformed Mesenchymal Stromal Cells Results in Complete Heterogeneity in Prostate Cancer Cells.

Ruoxiang Wang, Peizhen Hu, Fubo Wang, Ji Lyu, Yan Ou, Mouad Edderkaoui, Yi Zhang, Michael S Lewis, Stephen J Pandol, Haiyen E Zhau and 1 more

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruoxiang WangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0003-2614-8292
Peizhen HuDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Fubo WangDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Ji LyuDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Yan OuDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Mouad EdderkaouiDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0002-2549-8242
Yi ZhangDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Michael S LewisDepartment of Medicine and Pathology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0002-1892-4127
Stephen J PandolDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.ORCID 0000-0003-0818-6017
Haiyen E ZhauDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Leland W K ChungDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

Funding

Prostate Cancer Bone Metastasis: Biology and TargetingP01CA098912 · NCI · EMORY UNIVERSITY · PI CHUNG, LELAND W.K. · 2003 to 2019
$24.0M
ROS Targeted Therapy for Lethal Prostate CancerR21CA256419 · NCI · CEDARS-SINAI MEDICAL CENTER · PI WANG, RUOXIANG, ZHANG, YI · 2021 to 2022
$425k
Functional characterization of PrLZ in prostate cancerR21CA112330 · NCI · EMORY UNIVERSITY · PI WANG, RUOXIANG · 2005 to 2006
$260k
NCI NIH HHS P01 CA098912NCI NIH HHS R21 CA112330NCI NIH HHS R21 CA256419NIH HHS CA098912NIH HHS CA112330
6 · The paper itself

Abstract

Tumor cells gain advantages in growth and survival by acquiring genotypic and phenotypic heterogeneity. Interactions with bystander cells in the tumor microenvironment contribute to the progression of heterogeneity. We have shown that fusion between tumor and bystander cells is one form of interaction, and that tumor-bystander cell fusion has contrasting effects. By trapping fusion hybrids in the heterokaryon or synkaryon state, tumor-bystander cell fusion prevents the progression of heterogeneity. However, if trapping fails, fusion hybrids will resume replication to form derivative clones with diverse genomic makeups and behavioral phenotypes. To determine the characteristics of bystander cells that influence the fate of fusion hybrids, we co-cultured prostate mesenchymal stromal cell lines and their spontaneously transformed sublines with LNCaP as well as HPE-15 prostate cancer cells. Subclones derived from cancer-stromal fusion hybrids were examined for genotypic and phenotypic diversifications. Both stromal cell lines were capable of fusing with cancer cells, but only fusion hybrids with the transformed stromal subline generated large numbers of derivative subclones. Each subclone had distinct cell morphologies and growth behaviors and was detected with complete genomic hybridization. The health conditions of the bystander cell compartment play a crucial role in the progression of tumor cell heterogeneity.

Indexed as

bystander cellscancer–stromal hybridizationcell fusionheterogeneity progressionstromal cell transformationtumor cells

Identifiers

PMID38473313
PMCPMC10931070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.